Topical Oestrogens and Antimuscarinics In The Treatment Of Detrusor Overactivity
Is There A Synergic Effect Of Topical Oestrogens When Associated To Antimuscarinics In The Treatment Of Symptomatic Detrusor Overactivity
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Phase
Phase
- Phase 2
- Phase 3
Contacts and Locations
Study Locations
-
-
-
Varese, Italy, 21100
- Department of Gynecology and Obstetrics - Università dell'Insubria
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All post-menopausal women with symptoms of overactive bladder and urodynamically proven pure detrusor overactivity
Exclusion Criteria:
- concomitant urodynamic stress incontinence
- documented recurrent urinary tract infections
- previous antimuscarinic treatment
- previous pelvic surgery
- concomitant systemic HRT
- history of breast or endometrial cancer
- neurological disease
- clinical contraindications to treatment with oestrogen or antimuscarinics
- patients included in other ongoing clinical trials
Study Plan
How is the study designed?
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: 1
arm 1: Tolterodine 4 mg once daily for 12 weeks
|
|
|
Experimental: 2
arm 2: Tolterodine 4 mg + local oestrogens once daily for 12 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Start
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Urologic Diseases
- Urinary Bladder Diseases
- Lower Urinary Tract Symptoms
- Urological Manifestations
- Urinary Bladder, Overactive
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Muscarinic Antagonists
- Cholinergic Antagonists
- Cholinergic Agents
- Urological Agents
- Hormones
- Hormones, Hormone Substitutes, and Hormone Antagonists
- Estrogens
- Tolterodine Tartrate
Other Study ID Numbers
Other Study ID Numbers
- local oestrogens 9/2003
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.